glp 1 agonist lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating Novo Nordisk vs Eli Lilly:

However, only five SOCs demonstrated statistically significant associations based on the predefined Reporting Odds Ratio (ROR) criteria, excluding product-related issues

GLP-1 receptor agonists available in the UK include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and lixisenatide (Lyxumia)

Download Sample Report of GLP-1 Analogues Market Size, Share & Forecast Report, 2025-2034 Please fill out the form to request a customized copy of the research report.

Higher likelihood of adverse effects

They must either have: BMI of at least 35 BMI of at least 30 plus a history of heart failure, uncontrolled hypertension or chronic kidney disease BMI of at least 27 plus prediabetes, a previous heart attack or stroke, or symptomatic peripheral artery disease